Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jacobus

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Blood Cancer Journal|July 30, 2016
Randomized phase III trial of consolidation therapy with bortezomib-lenalidomide-Dexamethasone (VRd) vs bortezomib-dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimenS J Jacobus, S V Rajkumar, M Weiss, et al.
Molecular Therapy Oncolytics|January 1, 2020
Calcium Influx Caused by ER Stress Inducers Enhances Oncolytic Adenovirus Enadenotucirev Replication and Killing through PKCα ActivationWilliam K Taverner, Egon J Jacobus, John Christianson, et al.
Disease Models & Mechanisms|June 20, 2018
Impaired β-cell glucokinase as an underlying mechanism in diet-induced diabetesBrian Lu, Kiran Kurmi, Miguel Munoz-Gomez, et al.
Journal for Immunotherapy of Cancer|June 15, 2018
Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cellsJanet Lei, Egon J Jacobus, William K Taverner, et al.
Cancer Gene Therapy|September 5, 2018
Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus ConferenceArthur Dyer, Richard Baugh, Suet Lin Chia, et al.
Journal for Immunotherapy of Cancer|November 23, 2019
Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samplesEleanor M Scott, Egon J Jacobus, Brian Lyons, et al.
British Journal of Haematology|September 10, 2011
Impact of high-risk classification by FISH: an eastern cooperative oncology group (ECOG) study E4A03Susanna J Jacobus, Shaji Kumar, Hajime Uno, et al.
Blood|August 24, 2011
Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasoneShaji K Kumar, Hajime Uno, Susanna J Jacobus, et al.
Stem Cells Translational Medicine|March 19, 2016
Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet RegenerationMoustafa M El Khatib, Seiga Ohmine, Egon J Jacobus, et al.
Cancer|November 15, 2018
A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancerRana R McKay, Lillian Werner, Susanna J Jacobus, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Blood Cancer Journal|July 30, 2016
Randomized phase III trial of consolidation therapy with bortezomib-lenalidomide-Dexamethasone (VRd) vs bortezomib-dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimenS J Jacobus, S V Rajkumar, M Weiss, et al.
Molecular Therapy Oncolytics|January 1, 2020
Calcium Influx Caused by ER Stress Inducers Enhances Oncolytic Adenovirus Enadenotucirev Replication and Killing through PKCα ActivationWilliam K Taverner, Egon J Jacobus, John Christianson, et al.
Disease Models & Mechanisms|June 20, 2018
Impaired β-cell glucokinase as an underlying mechanism in diet-induced diabetesBrian Lu, Kiran Kurmi, Miguel Munoz-Gomez, et al.
Journal for Immunotherapy of Cancer|June 15, 2018
Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cellsJanet Lei, Egon J Jacobus, William K Taverner, et al.
Cancer Gene Therapy|September 5, 2018
Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus ConferenceArthur Dyer, Richard Baugh, Suet Lin Chia, et al.
Journal for Immunotherapy of Cancer|November 23, 2019
Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samplesEleanor M Scott, Egon J Jacobus, Brian Lyons, et al.
British Journal of Haematology|September 10, 2011
Impact of high-risk classification by FISH: an eastern cooperative oncology group (ECOG) study E4A03Susanna J Jacobus, Shaji Kumar, Hajime Uno, et al.
Blood|August 24, 2011
Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasoneShaji K Kumar, Hajime Uno, Susanna J Jacobus, et al.
Stem Cells Translational Medicine|March 19, 2016
Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet RegenerationMoustafa M El Khatib, Seiga Ohmine, Egon J Jacobus, et al.
Cancer|November 15, 2018
A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancerRana R McKay, Lillian Werner, Susanna J Jacobus, et al.
Pageof 4